• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Eton Pharmaceuticals

Eton Pharmaceuticals, Inc to Acquire Increlex® (mecasermin injection) from Ipsen
October 03, 2024
From Eton Pharmaceuticals
Via GlobeNewswire
Tickers ETON
Eton Pharmaceuticals to Participate at the H.C. Wainwright 26th Annual Global Investment Conference
August 22, 2024
From Eton Pharmaceuticals
Via GlobeNewswire
Tickers ETON
Eton Pharmaceuticals Reports Second Quarter 2024 Financial Results
August 08, 2024
From Eton Pharmaceuticals
Via GlobeNewswire
Tickers ETON
Eton Pharmaceuticals to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024
July 30, 2024
From Eton Pharmaceuticals
Via GlobeNewswire
Tickers ETON
Eton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-400 (Hydrocortisone Oral Solution)
July 15, 2024
From Eton Pharmaceuticals
Via GlobeNewswire
Tickers ETON
Eton Pharmaceuticals Reports First Quarter 2024 Financial Results
May 09, 2024
From Eton Pharmaceuticals
Via GlobeNewswire
Tickers ETON
Eton Pharmaceuticals to Present at the Citizens JMP Life Sciences Conference
May 01, 2024
From Eton Pharmaceuticals
Via GlobeNewswire
Tickers ETON
Eton Pharmaceuticals Announces Submission to FDA of New Drug Application for ET-400 (Hydrocortisone Oral Solution)
April 30, 2024
From Eton Pharmaceuticals
Via GlobeNewswire
Tickers ETON
Eton Pharmaceuticals to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024
April 29, 2024
From Eton Pharmaceuticals
Via GlobeNewswire
Tickers ETON
Eton Pharmaceuticals Announces Acquisition of PKU GOLIKE® for Phenylketonuria
March 22, 2024
From Eton Pharmaceuticals
Via GlobeNewswire
Tickers ETON RLFTF RLFTY
Eton Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results
March 14, 2024
From Eton Pharmaceuticals
Via GlobeNewswire
Tickers ETON
Eton Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 14, 2024
February 29, 2024
From Eton Pharmaceuticals
Via GlobeNewswire
Tickers ETON
Eton Pharmaceuticals Awarded U.S. Patent for Proprietary Hydrocortisone Oral Liquid Formulation
February 21, 2024
From Eton Pharmaceuticals
Via GlobeNewswire
Tickers ETON
Eton Pharmaceuticals Announces Commercial Availability of Ultra-Rare Disease Product Nitisinone Capsules
February 02, 2024
From Eton Pharmaceuticals
Via GlobeNewswire
Tickers ETON
Eton Pharmaceuticals Reports Third Quarter 2023 Financial Results
November 09, 2023
From Eton Pharmaceuticals
Via GlobeNewswire
Tickers ETON
Eton Pharmaceuticals to Report Third Quarter 2023 Financial Results on Thursday, November 9, 2023
October 30, 2023
From Eton Pharmaceuticals
Via GlobeNewswire
Tickers ETON
Eton Pharmaceuticals Announces Acquisition of FDA-Approved Ultra-Rare Disease Product Nitisinone
October 04, 2023
From Eton Pharmaceuticals
Via GlobeNewswire
Tickers ETON
Eton Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference
August 23, 2023
From Eton Pharmaceuticals
Via GlobeNewswire
Tickers ETON
Eton Pharmaceuticals Reports Second Quarter 2023 Financial Results
August 10, 2023
From Eton Pharmaceuticals
Via GlobeNewswire
Tickers ETON
Eton Pharmaceuticals to Report Second Quarter 2023 Financial Results on Thursday, August 10, 2023
August 01, 2023
From Eton Pharmaceuticals
Via GlobeNewswire
Tickers ETON
Eton Pharmaceuticals Receives Complete Response Letter (CRL) for Dehydrated Alcohol Injection
June 28, 2023
From Eton Pharmaceuticals
Via GlobeNewswire
Tickers ETON
Eton Pharmaceuticals Reports First Quarter 2023 Financial Results
May 11, 2023
From Eton Pharmaceuticals
Via GlobeNewswire
Tickers ETON
Eton Pharmaceuticals Announces Commercial Availability of Betaine Anhydrous for Oral Solution, a Generic Version of Cystadane® (betaine anhydrous for oral solution)
May 10, 2023
From Eton Pharmaceuticals
Via GlobeNewswire
Tickers ETON
Eton Pharmaceuticals to Report First Quarter 2023 Financial Results on Thursday, May 11, 2023
May 03, 2023
From Eton Pharmaceuticals
Via GlobeNewswire
Tickers ETON
Eton Pharmaceuticals Reports Fourth Quarter 2022 Financial Results
March 16, 2023
From Eton Pharmaceuticals
Via GlobeNewswire
Tickers ETON
Eton Pharmaceuticals Announces Acquisition of Rare Disease Product Candidate ET-600
March 15, 2023
From Eton Pharmaceuticals
Via GlobeNewswire
Tickers ETON
Eton Pharmaceuticals to Report Fourth Quarter 2022 Financial Results on Thursday, March 16, 2023
March 07, 2023
From Eton Pharmaceuticals
Via GlobeNewswire
Tickers ETON
Eton Pharmaceuticals Announces FDA Acceptance of NDA Response for Dehydrated Alcohol Injection
January 11, 2023
From Eton Pharmaceuticals
Via GlobeNewswire
Tickers ETON
Eton Pharmaceuticals Reports Third Quarter 2022 Financial Results
November 10, 2022
From Eton Pharmaceuticals
Via GlobeNewswire
Tickers ETON
Eton Pharmaceuticals to Report Third Quarter 2022 Financial Results on Thursday, November 10, 2022
November 02, 2022
From Eton Pharmaceuticals
Via GlobeNewswire
Tickers ETON
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap